Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Wiphawan Wasenang"'
Autor:
Arisara Poosari, Thitima Nutravong, Wises Namwat, Wiphawan Wasenang, Prakasit Sa-ngiamwibool, Piti Ungareewittaya
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract DNA methylation can regulate the expression of tumour suppressor genes P16 and TP53, environmental factors, which are both important factors related to an increased risk and prognosis of oesophageal cancer (EC). However, the association betw
Externí odkaz:
https://doaj.org/article/55b31630ca244bd4b6114a49e90b4e28
Autor:
David K. Lau, Dmitri Mouradov, Wiphawan Wasenang, Ian Y. Luk, Cameron M. Scott, David S. Williams, Yvonne H. Yeung, Temduang Limpaiboon, George F. Iatropoulos, Laura J. Jenkins, Camilla M. Reehorst, Fiona Chionh, Mehrdad Nikfarjam, Daniel Croagh, Amardeep S. Dhillon, Andrew J. Weickhardt, Toshihide Muramatsu, Yoshimasa Saito, Niall C. Tebbutt, Oliver M. Sieber, John M. Mariadason
Publikováno v:
iScience, Vol 21, Iss , Pp 624-637 (2019)
Summary: Biliary tract cancers (BTCs) currently have no approved targeted therapies. Although genomic profiling of primary BTCs has identified multiple potential drug targets, accurate models are needed for their evaluation. Genomic profiling of 22 B
Externí odkaz:
https://doaj.org/article/60855650f6624ff1817442e9b3685ec7
Publikováno v:
Clinical Epigenetics, Vol 11, Iss 1, Pp 1-10 (2019)
Abstract Background Cholangiocarcinoma (CCA) is a fatal cancer of the bile duct epithelial cell lining. The misdiagnosis of CCA and other biliary diseases may occur due to the similarity of clinical manifestations and blood tests resulting in inappro
Externí odkaz:
https://doaj.org/article/703ca35ecc2340ff86f5e84b82d2af73
Autor:
RICUPHAN KHAMKO, WIPHAWAN WASENANG, JUREERUT DADUANG, CHATRI SETTASATIAN, TEMDUANG LIMPAIBOON
Publikováno v:
In Vivo
Background/Aim: Cholangiocarcinoma (CCA) is a type of liver cancer originating from bile duct epithelium which has an unfavorable prognosis. Therefore, novel prognostic markers and effective therapeutic regimens are required. Opioid-binding protein/c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7597d52ea5aaac9f467b69f495286885
https://pubmed.ncbi.nlm.nih.gov/35478117
https://pubmed.ncbi.nlm.nih.gov/35478117
Autor:
Arisara, Poosari, Thitima, Nutravong, Wises, Namwat, Wiphawan, Wasenang, Prakasit, Sa-Ngiamwibool, Piti, Ungareewittaya
Publikováno v:
Scientific reports. 12(1)
DNA methylation can regulate the expression of tumour suppressor genes P16 and TP53, environmental factors, which are both important factors related to an increased risk and prognosis of oesophageal cancer (EC). However, the association between these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6d750d07a0b99275877ae6530471680f
https://pubmed.ncbi.nlm.nih.gov/35725923
https://pubmed.ncbi.nlm.nih.gov/35725923
Autor:
Wiphawan Wasenang, Amardeep S. Dhillon, Yvonne Yeung, Temduang Limpaiboon, Dmitri Mouradov, Oliver M. Sieber, Daniel Croagh, Ian Y. Luk, Laura J. Jenkins, Niall C. Tebbutt, George F. Iatropoulos, Toshihide Muramatsu, Camilla M. Reehorst, Andrew Weickhardt, Cameron M. Scott, David K. Lau, Yoshimasa Saito, John M. Mariadason, Mehrdad Nikfarjam, David S. Williams, Fiona Chionh
Publikováno v:
iScience
iScience, Vol 21, Iss, Pp 624-637 (2019)
iScience, Vol 21, Iss, Pp 624-637 (2019)
Summary Biliary tract cancers (BTCs) currently have no approved targeted therapies. Although genomic profiling of primary BTCs has identified multiple potential drug targets, accurate models are needed for their evaluation. Genomic profiling of 22 BT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc3526afc298fb64ec8baa8f27fb0470
https://pubmed.ncbi.nlm.nih.gov/31731200
https://pubmed.ncbi.nlm.nih.gov/31731200
Autor:
Wiphawan Wasenang, Temduang Limpaiboon, Siriporn Proungvitaya, Chatri Settasatian, Anucha Puapairoj
Publikováno v:
Pathology, research and practice. 215(7)
Cholangiocarcinoma (CCA) is a fatal liver cancer arising from bile duct epithelium. Polycomb repressive complex 2 (PRC2) is a histone methyltransferase enzyme that catalyzes trimethylation of histone H3 on lysine 27, resulting transcriptional gene si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d13bf083f1657a9bae20d13ff148cc2
https://pubmed.ncbi.nlm.nih.gov/31126817
https://pubmed.ncbi.nlm.nih.gov/31126817
Publikováno v:
Clinical Epigenetics
Clinical Epigenetics, Vol 11, Iss 1, Pp 1-10 (2019)
Clinical Epigenetics, Vol 11, Iss 1, Pp 1-10 (2019)
Background Cholangiocarcinoma (CCA) is a fatal cancer of the bile duct epithelial cell lining. The misdiagnosis of CCA and other biliary diseases may occur due to the similarity of clinical manifestations and blood tests resulting in inappropriate or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7262271c15e201e9958f6490ce99b065
http://europepmc.org/articles/PMC6399934
http://europepmc.org/articles/PMC6399934
Autor:
Siriporn Proungvitaya, Anucha Puapairoj, Wiphawan Wasenang, Temduang Limpaiboon, Chatri Settasatian
BACKGROUND: Cholangiocarcinoma (CCA) is a fatal liver cancer arising from bile duct epithelium. Polycomb repressive complex 2 (PRC2) is a histone methyltransferase enzyme that catalyzes trimethylation of histone H3 on lysine 27, resulting transcripti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4029be8dd4c92466b3dd49415d8916db
https://europepmc.org/articles/PMC6421193/
https://europepmc.org/articles/PMC6421193/
Figure S1. The optimization of OPCML MS-HRM assay using standard serial dilution series (0–100% methylation). Figure S2. The optimization of HOXA9 MS-HRM assay using standard serial dilution series (0–100% methylation). Figure S3. The optimizatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e9475a261151f3a158b66984baacf38